PPADS selectively antagonizes P2X-purinoceptor-mediated responses in the rabbit urinary bladder

Br J Pharmacol. 1993 Dec;110(4):1491-5. doi: 10.1111/j.1476-5381.1993.tb13990.x.

Abstract

1. Pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS), an inhibitor of P2X-purinoceptor-mediated responses in rabbit vas deferens, was investigated for its ability to antagonize contractions evoked by alpha,beta-methylene ATP (alpha,beta-MeATP), carbachol and electrical field stimulation in the rabbit urinary bladder detrusor muscle. 2. PPADS. (1-30 microM) caused concentration-dependent inhibition of contractions to the stable P2X-purinoceptor agonist, alpha,beta-MeATP, decreasing the maximum response to alpha,beta-MeATP (30 microM) at concentrations of 3-30 microM. The pD2 value for alpha,beta-MeATP in the absence of PPADS was 6.52 +/- 0.10 (8). In the presence of PPADS at concentrations of 1, 3, 10 and 30 microM the negative log concentrations of alpha,beta-MeATP that cause the same contractile response as the pD2 value were significantly different from control, being respectively 6.17 +/- 0.09 (8), 5.64 +/- 0.12 (7), 5.15 +/- 0.23 (7) and 4.78 +/- 0.22 (5). 3. PPADS (1-30 microM) caused concentration-dependent inhibition of contractions to stimulation of intramural purinergic nerves (1-32 Hz). There was a greater inhibition at lower frequencies (1-8 Hz) than at higher frequencies (16-32 Hz). PPADS, 30 microM, did not produce significantly greater antagonism than 10 microM. 4. PPADS (30 microM) had no significant influence on the contractile potency of carbachol: the pD2 values of carbachol in the absence and presence of PPADS were not significantly different being 6.42 +/- 0.16 (5) and 6.33 +/- 0.18 (5), respectively. However, PPADS caused a small, but significant, suppression of the maximal response of carbachol, reducing it by approximately 9%. 5. Radioligand binding studies carried out on rabbit bladder membranes with [3H]-alpha,beta-methylene ATP([3H]-alpha,beta-MeATP) showed that PPADS concentration-dependently inhibited the binding of [3H]-alpha,beta-MeATP to P2X-purinoceptors, while the binding of [3H]-quinuclidinyl benzilate to muscarinic cholinoceptors was not affected.6. Thus, PPADS (1-30 microM) antagonized responses mediated via P2X-purinoceptors in the rabbit urinary bladder. It was selective for P2-purinoceptor-mediated contractions rather than those mediated via muscarinic receptors. Binding studies demonstrated that the antagonistic effect of PPADS is via a direct interaction with P2x-purinoceptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / analogs & derivatives
  • Adenosine Triphosphate / metabolism
  • Animals
  • Carbachol / pharmacology
  • Dose-Response Relationship, Drug
  • In Vitro Techniques
  • Male
  • Muscle Contraction / drug effects
  • Purinergic P2 Receptor Antagonists*
  • Pyridoxal Phosphate / analogs & derivatives*
  • Pyridoxal Phosphate / pharmacology
  • Rabbits
  • Receptors, Purinergic P2 / physiology
  • Urinary Bladder / drug effects*
  • Urinary Bladder / physiology

Substances

  • Purinergic P2 Receptor Antagonists
  • Receptors, Purinergic P2
  • pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid
  • Pyridoxal Phosphate
  • Adenosine Triphosphate
  • Carbachol
  • alpha,beta-methyleneadenosine 5'-triphosphate